Development Trajectories in the Biotechnology Industry： China versus Leading Countries

The present paper examines China＇s biotechnology industry from a global perspective and explores how its development trajectory differs from that of countries that are leaders in biotechnology. We draw on diverse data to demonstrate the unique development trajectory of the industry in China. China h...

Full description

Saved in:
Bibliographic Details
Published inChina & world economy Vol. 19; no. 3; pp. 105 - 123
Main Authors Chen, Yantai, Luo, Laijun, Zhang, Yaguang
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.05.2011
Wiley Subscription Services, Inc
Subjects
Biotechnology
Biotechnology industry
China
Development
development trajectories
Economic development
Economic growth
F02
Foreign investment
global innovation network
Innovation
Innovations
institutional regime
L22
Leaders
O32
Studies
世界
中国
创新能力
可持续发展
国内企业
国家领导人
生物技术产业
自主创新
China
Online AccessGet full text

Cover

More Information
Summary:The present paper examines China＇s biotechnology industry from a global perspective and explores how its development trajectory differs from that of countries that are leaders in biotechnology. We draw on diverse data to demonstrate the unique development trajectory of the industry in China. China has benefited through targeted spin-offs of R＆D-oriented foreign direct investment from developed countries driven by the effects of globalization, government-encouraged collaboration between the domestic academia and industry, and the input of overseas returnees. Together with an increasing focus of the government and domestic enterprises on independent innovation, such developments have enabled China to catch up with the global biotechnology industry. However, its small scale and low capacity for commercializing innovations under China ＂s current regulations and other barriers pose challenges for the development of the industry. Suggestions for the sustainable development of China＇s biotechnology industry are presented in this study.
Bibliography:The present paper examines China＇s biotechnology industry from a global perspective and explores how its development trajectory differs from that of countries that are leaders in biotechnology. We draw on diverse data to demonstrate the unique development trajectory of the industry in China. China has benefited through targeted spin-offs of R＆D-oriented foreign direct investment from developed countries driven by the effects of globalization, government-encouraged collaboration between the domestic academia and industry, and the input of overseas returnees. Together with an increasing focus of the government and domestic enterprises on independent innovation, such developments have enabled China to catch up with the global biotechnology industry. However, its small scale and low capacity for commercializing innovations under China ＂s current regulations and other barriers pose challenges for the development of the industry. Suggestions for the sustainable development of China＇s biotechnology industry are presented in this study.
11-4639/F
biotechnology industry, development trajectories, global innovation network, institutional regime
ark:/67375/WNG-05K2F7FZ-3
ArticleID:CWE1245
istex:DD71ADF6F0504E58BA78B25DA97B3BECB1940E8C
The authors give their sincere thanks for the financial support from the National Science Foundation of China (No. 71003061), the Alexander von Humboldt Foundation (2007–2008), the Special Support Fund for China's Postdoctor Research Fellow (201003090) and the Humanities and the Social Sciences Project of the Ministry of Education (09YJC630225). The first author gives thanks to China Institute for Science and Technology Policy of Tsinghua University for supporting the research
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1671-2234
1749-124X
DOI:10.1111/j.1749-124X.2011.01245.x